$DX
DYNEX CAPITAL INC Stock $dx

$dx Overview Financials Valuation SEC Filings Company Website

2017 Q2 Form 10-Q Financial Statement

#000082667517000026 Filed on May 10, 2017

Income Statement

Concept	2017 Q2	2017 Q1	2016 Q1
Revenue	$24.90M	$22.40M	$25.10M
YoY Change	9.21%	-10.76%	4.15%
Cost Of Revenue	$8.700M	$7.500M	$6.300M
YoY Change	42.62%	19.05%	16.67%
Gross Profit	$16.10M	$14.90M	$18.80M
YoY Change	-3.59%	-20.74%	0.53%
Gross Profit Margin	64.66%	66.52%	74.9%
Selling, General & Admin	$4.100M	$4.300M	$4.100M
YoY Change	10.81%	4.88%	-4.65%
% of Gross Profit	25.47%	28.86%	21.81%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$400.0K	$300.0K	$500.0K
YoY Change	0.0%	-40.0%	-66.67%
% of Gross Profit	2.48%	2.01%	2.66%
Operating Expenses	$4.100M	$4.400M	$4.000M
YoY Change	24.24%	10.0%	-4.76%
Operating Profit	$12.00M	$10.50M	$14.80M
YoY Change	-10.45%	-29.05%	2.07%
Interest Expense	$8.714M	$7.519M	$6.310M
YoY Change	42.85%	19.16%	17.48%
% of Operating Profit	72.62%	71.61%	42.64%
Other Income/Expense, Net	$4.000K	-$46.00K	$87.00K
YoY Change	-98.74%	-152.87%	20.83%
Pretax Income	-$7.400M	$9.100M	-$37.40M
YoY Change	131.25%	-124.33%	293.68%
Income Tax
% Of Pretax Income
Net Earnings	-$7.432M	$9.051M	-$37.43M
YoY Change	130.02%	-124.18%	295.18%
Net Earnings / Revenue	-29.85%	40.41%	-149.13%
Basic Earnings Per Share
Diluted Earnings Per Share	-$451.2K	$554.9K	-$2.294M
COMMON SHARES
Basic Shares Outstanding	49.20M shares	49.19M shares	48.95M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2017 Q2	2017 Q1	2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$100.9M	$65.90M	$82.90M
YoY Change	4.13%	-20.51%	115.32%
Cash & Equivalents	$100.9M	$65.94M	$82.94M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$25.10M	$27.40M	$28.50M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$126.0M	$93.30M	$111.4M
YoY Change	1.37%	-16.25%	58.92%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$2.881B	$3.205B	$98.00K
YoY Change		3270206.12%	-99.02%
Other Assets	$45.40M	$34.80M	$86.90M
YoY Change	-45.76%	-59.95%	29.7%
Total Long-Term Assets	$2.934B	$3.247B	$3.473B
YoY Change	-12.27%	-6.51%	-13.3%
TOTAL ASSETS
Total Short-Term Assets	$126.0M	$93.30M	$111.4M
Total Long-Term Assets	$2.934B	$3.247B	$3.473B
Total Assets	$3.060B	$3.340B	$3.584B
YoY Change	-11.79%	-6.81%	-12.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$1.500M	$2.600M	$2.200M
YoY Change	-11.76%	18.18%	-4.35%
Deferred Revenue
YoY Change
Short-Term Debt	$2.541B	$2.826B	$2.985B
YoY Change	-11.27%	-5.33%	-6.3%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.553B	$2.839B	$2.999B
YoY Change	-11.26%	-5.33%	-11.77%
LONG-TERM LIABILITIES
Long-Term Debt	$5.900M	$6.100M	$8.100M
YoY Change	-21.33%	-24.69%	-20.59%
Other Long-Term Liabilities	$3.600M	$1.800M	$92.60M
YoY Change	-96.11%	-98.06%	53.82%
Total Long-Term Liabilities	$9.500M	$7.900M	$100.7M
YoY Change	-90.51%	-92.15%	43.04%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.553B	$2.839B	$2.999B
Total Long-Term Liabilities	$9.500M	$7.900M	$100.7M
Total Liabilities	$2.563B	$2.847B	$3.100B
YoY Change	-13.92%	-8.16%	-10.66%
SHAREHOLDERS EQUITY
Retained Earnings	-$359.2M	-$340.3M	-$380.7M
YoY Change	-9.42%	-10.62%	21.61%
Common Stock	$728.1M	$727.5M	$725.9M
YoY Change	0.22%	0.22%	-5.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$497.3M	$492.5M	$483.8M
YoY Change
Total Liabilities & Shareholders Equity	$3.060B	$3.340B	$3.584B
YoY Change	-11.79%	-6.81%	-12.06%

Cashflow Statement

Concept	2017 Q2	2017 Q1	2016 Q1
OPERATING ACTIVITIES
Net Income	-$7.432M	$9.051M	-$37.43M
YoY Change	130.02%	-124.18%	295.18%
Depreciation, Depletion And Amortization	$400.0K	$300.0K	$500.0K
YoY Change	0.0%	-40.0%	-66.67%
Cash From Operating Activities	$55.90M	$47.11M	$53.60M
YoY Change	6.27%	-12.12%	5.19%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$275.5M	$146.0K	$38.00K
YoY Change	196.56%	284.21%	-49.33%
Cash From Investing Activities	$275.5M	$33.70M	$170.6M
YoY Change	196.56%	-80.25%	-191.13%
FINANCING ACTIVITIES
Cash Dividend Paid		$12.63M	$14.07M
YoY Change		-10.24%	-11.97%
Common Stock Issuance & Retirement, Net		-$127.0K	$254.0K
YoY Change		-150.0%	151.49%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-286.0M	-$78.93M	-$175.2M
YoY Change	117.33%	-54.95%	-233.93%
NET CHANGE
Cash From Operating Activities	55.90M	$47.11M	$53.60M
Cash From Investing Activities	275.5M	$33.70M	$170.6M
Cash From Financing Activities	-286.0M	-$78.93M	-$175.2M
Net Change In Cash	45.40M	$1.876M	$49.01M
YoY Change	226.62%	-96.17%	-1000.83%
FREE CASH FLOW
Cash From Operating Activities	$55.90M	$47.11M	$53.60M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q1	dx	Number Of Counterparties Borrowings Outstanding NumberOfCounterpartiesBorrowingsOutstanding	18	Agreements
CY2016Q4	invest	Derivative Notional Amount DerivativeNotionalAmount	3880000000	USD
CY2017Q1	invest	Derivative Notional Amount DerivativeNotionalAmount	4545000000	USD
CY2017Q1	dei	Amendment Flag AmendmentFlag	false
CY2017Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2017Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2017Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017Q1	dei	Document Period End Date DocumentPeriodEndDate	2017-03-31
CY2017Q1	dei	Document Type DocumentType	10-Q
CY2017Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000826675
CY2017Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	49204773	shares
CY2017Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2017Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2016Q2	dei	Entity Public Float EntityPublicFloat	310217722	USD
CY2017Q1	dei	Entity Registrant Name EntityRegistrantName	DYNEX CAPITAL INC
CY2017Q1	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2017Q1	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2016Q4	dx	Investments Unamortized Premium Discount InvestmentsUnamortizedPremiumDiscount	822084000	USD
CY2017Q1	dx	Investments Unamortized Premium Discount InvestmentsUnamortizedPremiumDiscount	816981000	USD
CY2017Q1	dx	Notional Amountof Derivative Instruments Added NotionalAmountofDerivativeInstrumentsAdded	1400000000	USD
CY2017Q1	dx	Notional Amountof Derivative Instruments Terminated NotionalAmountofDerivativeInstrumentsTerminated	735000000	USD
CY2017Q1	dx	Number Of Counterparties Borrowing Availability NumberOfCounterpartiesBorrowingAvailability	31	Agreements
CY2017Q1	us-gaap	Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax	572000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-32609000	USD
CY2017Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-12632000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	727369000	USD
CY2017Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	727503000	USD
CY2016Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	37547000	USD
CY2017Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	39862000	USD
CY2017Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	521000	USD
CY2017Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	45000	USD
CY2016Q4	us-gaap	Assets Assets	3397731000	USD
CY2017Q1	us-gaap	Assets Assets	3339874000	USD
CY2016Q4	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	3240618000	USD
CY2017Q1	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	3187021000	USD
CY2016Q4	us-gaap	Assets Sold Under Agreements To Repurchase Interest Rate AssetsSoldUnderAgreementsToRepurchaseInterestRate	0.0103
CY2017Q1	us-gaap	Assets Sold Under Agreements To Repurchase Interest Rate AssetsSoldUnderAgreementsToRepurchaseInterestRate	0.0115
CY2016Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	19643000	USD
CY2017Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	23541000	USD
CY2016Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	52526000	USD
CY2017Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	36393000	USD
CY2016Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	3244967000	USD
CY2017Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	3199601000	USD
CY2016Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	3212084000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	3186749000	USD
CY2016Q1	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	-3941000	USD
CY2017Q1	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	1708000	USD
CY2016Q1	us-gaap	Available For Sale Securities Gross Realized Gains Losses Sale Proceeds AvailableForSaleSecuritiesGrossRealizedGainsLossesSaleProceeds	77530000	USD
CY2017Q1	us-gaap	Available For Sale Securities Gross Realized Gains Losses Sale Proceeds AvailableForSaleSecuritiesGrossRealizedGainsLossesSaleProceeds	57164000	USD
CY2016Q1	us-gaap	Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments	-3941000	USD
CY2017Q1	us-gaap	Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments	-1708000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33935000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	82940000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	74120000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	65943000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	49005000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-8177000	USD
CY2017Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.18
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2017Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49153463	shares
CY2017Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49203022	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49153463	shares
CY2017Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49203022	shares
CY2016Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	492000	USD
CY2017Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	492000	USD
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2003000	USD
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	26593000	USD
CY2016Q4	us-gaap	Derivative Asset Notional Amount DerivativeAssetNotionalAmount	2670000000	USD
CY2017Q1	us-gaap	Derivative Asset Notional Amount DerivativeAssetNotionalAmount	3695000000	USD
CY2016Q4	us-gaap	Derivative Assets DerivativeAssets	28534000	USD
CY2017Q1	us-gaap	Derivative Assets DerivativeAssets	272000	USD
CY2016Q4	us-gaap	Derivative Average Forward Interest Rate DerivativeAverageForwardInterestRate	0.0218
CY2017Q1	us-gaap	Derivative Average Forward Interest Rate DerivativeAverageForwardInterestRate	0.0216
CY2016Q4	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	22085000	USD
CY2017Q1	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	0	USD
CY2016Q4	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	6449000	USD
CY2017Q1	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	29000	USD
CY2016Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	USD
CY2017Q1	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	USD
CY2016Q4	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	6913000	USD
CY2017Q1	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	58000	USD
CY2016Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	28534000	USD
CY2017Q1	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	272000	USD
CY2016Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral	28534000	USD
CY2017Q1	us-gaap	Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral	272000	USD
CY2016Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	0	USD
CY2017Q1	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	243000	USD
CY2016Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	6922000	USD
CY2017Q1	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	58000	USD
CY2016Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral	6922000	USD
CY2017Q1	us-gaap	Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral	58000	USD
CY2016Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral	9000	USD
CY2017Q1	us-gaap	Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral	0	USD
CY2016Q4	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue	28534000	USD
CY2017Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue	272000	USD
CY2016Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-48264000	USD
CY2017Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	175000	USD
CY2016Q4	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue	6922000	USD
CY2017Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue	58000	USD
CY2016Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	6922000	USD
CY2017Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	58000	USD
CY2016Q4	us-gaap	Derivative Liability Notional Amount DerivativeLiabilityNotionalAmount	1210000000	USD
CY2017Q1	us-gaap	Derivative Liability Notional Amount DerivativeLiabilityNotionalAmount	850000000	USD
CY2017Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	8857000	USD
CY2016Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	12268000	USD
CY2017Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	10934000	USD
CY2017Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	2435000	USD
CY2016Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.81
CY2017Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.13
CY2017Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y8M21D
CY2017Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	2334000	USD
CY2016Q4	us-gaap	Financial Instruments Owned And Pledged As Collateral At Fair Value FinancialInstrumentsOwnedAndPledgedAsCollateralAtFairValue	3150610000	USD
CY2017Q1	us-gaap	Financial Instruments Owned And Pledged As Collateral At Fair Value FinancialInstrumentsOwnedAndPledgedAsCollateralAtFairValue	3070435000	USD
CY2016Q4	us-gaap	Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue	3212084000	USD
CY2017Q1	us-gaap	Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue	3186749000	USD
CY2016Q1	us-gaap	Gain Loss On Sales Of Mortgage Backed Securities Mbs GainLossOnSalesOfMortgageBackedSecuritiesMBS	-3941000	USD
CY2017Q1	us-gaap	Gain Loss On Sales Of Mortgage Backed Securities Mbs GainLossOnSalesOfMortgageBackedSecuritiesMBS	-1708000	USD
CY2016Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-613000	USD
CY2017Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	2453000	USD
CY2016Q1	us-gaap	Increase Decrease In Financial Instruments Used In Operating Activities IncreaseDecreaseInFinancialInstrumentsUsedInOperatingActivities	-48264000	USD
CY2017Q1	us-gaap	Increase Decrease In Financial Instruments Used In Operating Activities IncreaseDecreaseInFinancialInstrumentsUsedInOperatingActivities	175000	USD
CY2016Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	500000	USD
CY2017Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-528000	USD
CY2016Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	1112000	USD
CY2017Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	1210000	USD
CY2016Q1	us-gaap	Increase In Restricted Cash IncreaseInRestrictedCash	35674000	USD
CY2017Q1	us-gaap	Increase In Restricted Cash IncreaseInRestrictedCash	10053000	USD
CY2016Q1	us-gaap	Interest Expense InterestExpense	6310000	USD
CY2017Q1	us-gaap	Interest Expense InterestExpense	7519000	USD
CY2016Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	18779000	USD
CY2017Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	14900000	USD
CY2016Q1	us-gaap	Interest Income Operating InterestIncomeOperating	25089000	USD
CY2017Q1	us-gaap	Interest Income Operating InterestIncomeOperating	22419000	USD
CY2016Q1	us-gaap	Interest Paid InterestPaid	5781000	USD
CY2017Q1	us-gaap	Interest Paid InterestPaid	8141000	USD
CY2016Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	3156000	USD
CY2017Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	2628000	USD
CY2016Q4	us-gaap	Interest Receivable InterestReceivable	20396000	USD
CY2017Q1	us-gaap	Interest Receivable InterestReceivable	22849000	USD
CY2016Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	2422883000	USD
CY2017Q1	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	2382620000	USD
CY2016Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2219000	USD
CY2017Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2245000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	2930547000	USD
CY2017Q1	us-gaap	Liabilities Liabilities	2847352000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3397731000	USD
CY2017Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3339874000	USD
CY2016Q4	us-gaap	Liabilities Fair Value Disclosure Recurring LiabilitiesFairValueDisclosureRecurring	6922000	USD
CY2017Q1	us-gaap	Liabilities Fair Value Disclosure Recurring LiabilitiesFairValueDisclosureRecurring	58000	USD
CY2017Q1	us-gaap	Line Of Credit LineOfCredit	345672000	USD
CY2017Q1	us-gaap	Line Of Credit Facility Interest Rate At Period End LineOfCreditFacilityInterestRateAtPeriodEnd	0.0185
CY2017Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	350000000	USD
CY2016Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	19036000	USD
CY2017Q1	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	18183000	USD
CY2016Q4	us-gaap	Long Term Debt LongTermDebt	6440000	USD
CY2017Q1	us-gaap	Long Term Debt LongTermDebt	6075000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-175185000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-88982000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	170586000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	33697000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	53604000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	47108000	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-37431000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	9051000	USD
CY2016Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-39725000	USD
CY2017Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6616000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	41728000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	19977000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-3941000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-1708000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	-27000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	99000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	37760000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	18368000	USD
CY2016Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	477000	USD
CY2017Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	325000	USD
CY2016Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1873000	USD
CY2017Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	2035000	USD
CY2016Q4	us-gaap	Other Liabilities OtherLiabilities	2809000	USD
CY2017Q1	us-gaap	Other Liabilities OtherLiabilities	1712000	USD
CY2016Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	63000	USD
CY2017Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-46000	USD
CY2016Q4	us-gaap	Other Receivables From Broker Dealers And Clearing Organizations OtherReceivablesFromBrokerDealersAndClearingOrganizations	11978000	USD
CY2017Q1	us-gaap	Other Receivables From Broker Dealers And Clearing Organizations OtherReceivablesFromBrokerDealersAndClearingOrganizations	4558000	USD
CY2016Q1	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	5992000	USD
CY2017Q1	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	-21573000	USD
CY2016Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	38000	USD
CY2017Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	146000	USD
CY2016Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	310000	USD
CY2017Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2016Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	14066000	USD
CY2017Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	12626000	USD
CY2016Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2017Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	36000	USD
CY2016Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	485000	USD
CY2017Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	521000	USD
CY2016Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	4970000	USD
CY2017Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	141436000	USD
CY2016Q4	us-gaap	Pledged Financial Instruments Not Separately Reported Securities For Repurchase Agreements PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesForRepurchaseAgreements	3149839000	USD
CY2017Q1	us-gaap	Pledged Financial Instruments Not Separately Reported Securities For Repurchase Agreements PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesForRepurchaseAgreements	3070075000	USD
CY2017Q1	us-gaap	Preferred Stock Dividend Payment Terms PreferredStockDividendPaymentTerms	The Series A Preferred Stock pays a cumulative cash dividend equivalent to 8.50% of the $25.00 liquidation preference per share each year and the Series B Preferred Stock pays a cumulative cash dividend equivalent to 7.625% of the $25.00 liquidation preference per share each year.
CY2016Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2294000	USD
CY2017Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2435000	USD
CY2017Q1	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	25.00
CY2016Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	114298000	USD
CY2017Q1	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	122428000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2017Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2017Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4571937	shares
CY2017Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4897138	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4571937	shares
CY2017Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4897138	shares
CY2016Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	110005000	USD
CY2017Q1	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	117473000	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	6814000	USD
CY2017Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	6498000	USD
CY2016Q1	us-gaap	Proceeds From Collection Of Finance Receivables ProceedsFromCollectionOfFinanceReceivables	899000	USD
CY2017Q1	us-gaap	Proceeds From Collection Of Finance Receivables ProceedsFromCollectionOfFinanceReceivables	987000	USD
CY2016Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	56000	USD
CY2017Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	127000	USD
CY2016Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	5403089000	USD
CY2017Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	21748733000	USD
CY2016Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	USD
CY2017Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	7504000	USD
CY2016Q1	us-gaap	Proceeds From Limited Partnership Investments ProceedsFromLimitedPartnershipInvestments	10737000	USD
CY2017Q1	us-gaap	Proceeds From Limited Partnership Investments ProceedsFromLimitedPartnershipInvestments	0	USD
CY2017Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	95546000	USD
CY2016Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	92420000	USD
CY2016Q1	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	-305000	USD
CY2017Q1	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	-370000	USD
CY2016Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	77530000	USD
CY2017Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	57173000	USD
CY2016Q1	us-gaap	Profit Loss ProfitLoss	-37431000	USD
CY2017Q1	us-gaap	Profit Loss ProfitLoss	9051000	USD
CY2016Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	5527490000	USD
CY2017Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	21821740000	USD
CY2016Q1	us-gaap	Repurchase Agreement Counterparty Weighted Average Maturity Of Agreements1 RepurchaseAgreementCounterpartyWeightedAverageMaturityOfAgreements1	P20D
CY2017Q1	us-gaap	Repurchase Agreement Counterparty Weighted Average Maturity Of Agreements1 RepurchaseAgreementCounterpartyWeightedAverageMaturityOfAgreements1	P18D
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	24769000	USD
CY2017Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	34822000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-338073000	USD
CY2017Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-340314000	USD
CY2016Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	2898952000	USD
CY2017Q1	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	2825945000	USD
CY2016Q4	us-gaap	Securities Sold Under Agreements To Repurchase Amount Offset Against Collateral SecuritiesSoldUnderAgreementsToRepurchaseAmountOffsetAgainstCollateral	0	USD
CY2017Q1	us-gaap	Securities Sold Under Agreements To Repurchase Amount Offset Against Collateral SecuritiesSoldUnderAgreementsToRepurchaseAmountOffsetAgainstCollateral	0	USD
CY2016Q4	us-gaap	Securities Sold Under Agreements To Repurchase Asset SecuritiesSoldUnderAgreementsToRepurchaseAsset	0	USD
CY2017Q1	us-gaap	Securities Sold Under Agreements To Repurchase Asset SecuritiesSoldUnderAgreementsToRepurchaseAsset	0	USD
CY2016Q4	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Cash SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash	0	USD
CY2017Q1	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Cash SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash	0	USD
CY2016Q4	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Securities SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities	2898952000	USD
CY2017Q1	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Securities SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities	2825945000	USD
CY2016Q4	us-gaap	Securities Sold Under Agreements To Repurchase Gross SecuritiesSoldUnderAgreementsToRepurchaseGross	2898952000	USD
CY2017Q1	us-gaap	Securities Sold Under Agreements To Repurchase Gross SecuritiesSoldUnderAgreementsToRepurchaseGross	2825945000	USD
CY2016Q1	us-gaap	Share Based Compensation ShareBasedCompensation	829000	USD
CY2017Q1	us-gaap	Share Based Compensation ShareBasedCompensation	538000	USD
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	168720	shares
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.77
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	108446	shares
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.22
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	696597	shares
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	547486	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	553396	shares
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	386151	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	8.54
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	7.63
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	7.55
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	7.05
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	317831	shares
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	275691	shares
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	8.87
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	7.94
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	2500000	shares
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	815682	shares
CY2017Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	7631000	USD
CY2017Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	537000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	467184000	USD
CY2017Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	492522000	USD
CY2016Q1	us-gaap	Trading Securities Unrealized Holding Gain Loss TradingSecuritiesUnrealizedHoldingGainLoss	24000	USD
CY2017Q1	us-gaap	Trading Securities Unrealized Holding Gain Loss TradingSecuritiesUnrealizedHoldingGainLoss	10000	USD
CY2016Q4	us-gaap	Transfers Accounted For As Secured Borrowings Associated Liabilities Carrying Amount TransfersAccountedForAsSecuredBorrowingsAssociatedLiabilitiesCarryingAmount	2898952000	USD
CY2017Q1	us-gaap	Transfers Accounted For As Secured Borrowings Associated Liabilities Carrying Amount TransfersAccountedForAsSecuredBorrowingsAssociatedLiabilitiesCarryingAmount	2825945000	USD
CY2016Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	49041000	shares
CY2017Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	49176000	shares
CY2017Q1	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recent Accounting Pronouncements</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2017-08, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Receivables-Nonrefundable Fees and Other Costs, </font><font style="font-family:inherit;font-size:10pt;">which shortens the amortization period for certain callable debt securities held at a premium, requiring the premium to be amortized to the earliest call date. The amendments in this ASU are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018 and early adoption is permitted. The amendments in this Update should be applied using the modified-retrospective transition approach and will require disclosures for the change in accounting principle. The Company is currently evaluating the impact of this ASU on its consolidated financial statements.</font></div></div>
CY2017Q1	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Organization</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dynex Capital, Inc., ("Company") was incorporated in the Commonwealth of Virginia on December 18, 1987 and commenced operations in February 1988. The Company primarily earns income from investing on a leveraged basis in mortgage-backed securities ("MBS") that are issued or guaranteed by the U.S. Government or U.S. Government sponsored agencies ("Agency MBS") and MBS issued by others ("non-Agency MBS").</font></div></div>
CY2017Q1	us-gaap	Reclassifications Reclassifications	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Reclassifications</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain items in the prior periods' consolidated financial statements have been reclassified to conform to the current period's presentation. The Company has reclassified amortization of stock issuance costs which was previously recorded in "proceeds from issuance of common stock, net of issuance costs" in the financing activities section of the Company's consolidated statements of cash flows for </font><font style="font-family:inherit;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;">. Amortization of stock issuance costs is now presented within "other operating activities" in the operating activities section of the Company's consolidated statements of cash flows. This presentation change had no effect on reported financial condition or results of operations and did not have a material impact on cash flows from operating or financing activities.</font></div></div>
CY2017Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates. The most significant estimates used by management include, but are not limited to, amortization of premiums and discounts, fair value measurements of its investments, and other-than-temporary impairments. These items are discussed further below within this note to the consolidated financial statements.</font></div><div style="line-height:120%;text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></div>

Files In Submission

Name	View Source	Status
0000826675-17-000026-index-headers.html	Edgar Link	pending
0000826675-17-000026-index.html	Edgar Link	pending
0000826675-17-000026.txt	Edgar Link	pending
0000826675-17-000026-xbrl.zip	Edgar Link	pending
a1q17form10-q.htm	Edgar Link	pending
a1q17form10-qexx121ratioof.htm	Edgar Link	pending
a1q17form10-qexx311ceocert.htm	Edgar Link	pending
a1q17form10-qexx312cfocert.htm	Edgar Link	pending
a1q17form10-qexx321soxcert.htm	Edgar Link	pending
a1q17form10-_chartx17331.jpg	Edgar Link	pending
a1q17form10-_chartx18589.jpg	Edgar Link	pending
a1q17form10-_chartx19534.jpg	Edgar Link	pending
a1q17form10-_chartx19947.jpg	Edgar Link	pending
a1q17form10-_chartx20730.jpg	Edgar Link	pending
a1q17form10-_chartx21996.jpg	Edgar Link	pending
a1q17form10-_chartx23081.jpg	Edgar Link	pending
a1q17form10-_chartx24448.jpg	Edgar Link	pending
a1q17form10-_chartx25643.jpg	Edgar Link	pending
a1q17form10-_chartx26682.jpg	Edgar Link	pending
a1q17form10-_chartx27774.jpg	Edgar Link	pending
a1q17form10-_chartx28759.jpg	Edgar Link	pending
a1q17form10-_chartx30150.jpg	Edgar Link	pending
a1q17form10-_chartx32398.jpg	Edgar Link	pending
dx-20170331.xml	Edgar Link	completed
dx-20170331.xsd	Edgar Link	pending
dx-20170331_cal.xml	Edgar Link	unprocessable
dx-20170331_def.xml	Edgar Link	unprocessable
dx-20170331_lab.xml	Edgar Link	unprocessable
dx-20170331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DX
DYNEX CAPITAL INC Stock $dx

2017 Q2 Form 10-Q Financial Statement

#000082667517000026 Filed on May 10, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DX DYNEX CAPITAL INC Stock $dx

2017 Q2 Form 10-Q Financial Statement

#000082667517000026 Filed on May 10, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DX
DYNEX CAPITAL INC Stock $dx